News Releases

Biogen Announces Webcast of Annual Meeting of Stockholders

June 4, 2018 at 9:00 AM EDT

Cambridge, MA, Biogen Inc. (NASDAQ: BIIB) announced today that the webcast of the Company's 2018 Annual Meeting of Stockholders will be held on Tuesday, June 12, 2018 at 9:00 a.m. Eastern Daylight Time.  A live audio webcast of the meeting will be available on the Investor Relations section of the Company's corporate website at www.biogen.com/investors or directly via www.virtualshareholdermeeting.com/BIIB2018. An archive of the webcast will be available for replay following the meeting.  Please allow at least 10 minutes prior to the event to visit the site and download the necessary software to listen to the webcast. 
About Biogen
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Founded in 1978 as one of the world’s first global biotechnology companies by Charles Weissmann, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, today Biogen has the leading portfolio of medicines to treat multiple sclerosis; has introduced the first and only approved treatment for spinal muscular atrophy; and is focused on advancing neuroscience research programs in Alzheimer’s disease and dementia, multiple sclerosis and neuroimmunology, movement disorders, neuromuscular disorders, pain, ophthalmology, neuropsychiatry, and acute neurology. Biogen also manufactures and commercializes biosimilars of advanced biologics. We routinely post information that may be important to investors on our website at www.biogen.com. To learn more, please visit www.biogen.com and follow us on social media – Twitter, LinkedIn, Facebook, YouTube.
 

Contact:
Karen Jewell
Investor Relations
Biogen
781.464.2442